Top

International Journal of Clinical Oncology

Published in:

01-12-2010 | Review Article

Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology

Author: Nobuyoshi Hiraoka

Published in: International Journal of Clinical Oncology | Issue 6/2010

Abstract

Tumor-infiltrating lymphocytes (TIL) are one of the representative components of host antitumor immune responses. Both the quality and quantity of TIL determine the effect of the antitumor immune reaction. Previous studies have indicated that patients with cancers showing massive infiltration of CD8⁺ T cells generally have a better clinical outcome. Conversely, patients with marked infiltration of immunosuppressive cells such as regulatory T cells tend to have a worse prognosis for several types of cancer. The density and distribution of TIL are also strongly affected by the trafficking route. Tumor-associated blood vessels in various cancers are structurally and functionally abnormal, and such abnormal vessels reportedly become an obstacle for infiltration of immune effector cells into tumors. Recently, understanding of the molecular mechanisms of lymphocyte trafficking has progressed rapidly. This review focuses on the mechanisms of lymphocyte trafficking to tumor cells and also discusses the importance of blood vessel for TIL trafficking, especially in relation to hepatocarcinogenesis.

von Andrian UH, Mackay CR (2000) T-cell function and migration. Two sides of the same coin. N Engl J Med 343:1020–1034CrossRef

Butcher EC, Picker LJ (1996) Lymphocyte homing and homeostasis. Science 272:60–66PubMedCrossRef

Friedl P, Weigelin B (2008) Interstitial leukocyte migration and immune function. Nat Immunol 9:960–969PubMedCrossRef

Luster AD, Alon R, von Andrian UH (2005) Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 6:1182–1190PubMedCrossRef

Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–1964PubMedCrossRef

Zhang L, Conejo-Garcia JR, Katsaros D et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203–213PubMedCrossRef

Wilke CM, Wu K, Zhao E et al (2010) Prognostic significance of regulatory T cells in tumor. Int J Cancer 127:748–758PubMed

Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6:295–307PubMedCrossRef

Curiel TJ (2008) Regulatory T cells and treatment of cancer. Curr Opin Immunol 20:241–246PubMedCrossRef

10.

Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301–314PubMedCrossRef

11.

Ley K, Laudanna C, Cybulsky MI et al (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7:678–689PubMedCrossRef

12.

Nourshargh S, Hordijk PL, Sixt M (2010) Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat Rev Mol Cell Biol 11:366–378PubMedCrossRef

13.

Lowe JB (2001) Glycosylation, immunity, and autoimmunity. Cell 104:809–812PubMedCrossRef

14.

Rosen SD (2004) Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 22:129–156PubMedCrossRef

15.

Fukuda M, Hiraoka N, Yeh JC (1999) C-type lectins and sialyl Lewis X oligosaccharides. Versatile roles in cell–cell interaction. J Cell Biol 147:467–470PubMedCrossRef

16.

Yeh JC, Hiraoka N, Petryniak B et al (2001) Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N-acetylglucosaminyltransferase. Cell 105:957–969PubMedCrossRef

17.

McEver RP (2002) Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol 14:581–586PubMedCrossRef

18.

Bos JL, Rehmann H, Wittinghofer A (2007) GEFs and GAPs: critical elements in the control of small G proteins. Cell 129:865–877PubMedCrossRef

19.

Cernuda-Morollon E, Ridley AJ (2006) Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells. Circ Res 98:757–767PubMedCrossRef

20.

Arnaout MA, Mahalingam B, Xiong JP (2005) Integrin structure, allostery, and bidirectional signaling. Annu Rev Cell Dev Biol 21:381–410PubMedCrossRef

21.

Ridley AJ, Schwartz MA, Burridge K et al (2003) Cell migration: integrating signals from front to back. Science 302:1704–1709PubMedCrossRef

22.

Barreiro O, de la Fuente H, Mittelbrunn M et al (2007) Functional insights on the polarized redistribution of leukocyte integrins and their ligands during leukocyte migration and immune interactions. Immunol Rev 218:147–164PubMedCrossRef

23.

Shulman Z, Shinder V, Klein E et al (2009) Lymphocyte crawling and transendothelial migration require chemokine triggering of high-affinity LFA-1 integrin. Immunity 30:384–396PubMedCrossRef

24.

Carman CV, Springer TA (2004) A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol 167:377–388PubMedCrossRef

25.

Barreiro O, Yanez-Mo M, Serrador JM et al (2002) Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Cell Biol 157:1233–1245PubMedCrossRef

26.

Feng D, Nagy JA, Pyne K et al (1998) Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med 187:903–915PubMedCrossRef

27.

Muller WA (2003) Leukocyte–endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24:327–334PubMed

28.

Vestweber D (2002) Regulation of endothelial cell contacts during leukocyte extravasation. Curr Opin Cell Biol 14:587–593PubMedCrossRef

29.

Woodfin A, Voisin MB, Imhof BA et al (2009) Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1. Blood 113:6246–6257PubMedCrossRef

30.

Millan J, Hewlett L, Glyn M et al (2006) Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nat Cell Biol 8:113–123PubMedCrossRef

31.

Engelhardt B, Wolburg H (2004) Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house? Eur J Immunol 34:2955–2963PubMedCrossRef

32.

Cinamon G, Shinder V, Shamri R et al (2004) Chemoattractant signals and beta 2 integrin occupancy at apical endothelial contacts combine with shear stress signals to promote transendothelial neutrophil migration. J Immunol 173:7282–7291PubMed

33.

Rowe RG, Weiss SJ (2008) Breaching the basement membrane: who, when and how? Trends Cell Biol 18:560–574PubMedCrossRef

34.

Leppert D, Waubant E, Galardy R et al (1995) T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154:4379–4389PubMed

35.

Mydel P, Shipley JM, Adair-Kirk TL et al (2008) Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils. J Biol Chem 283:9513–9522PubMedCrossRef

36.

Friedl P, Entschladen F, Conrad C et al (1998) CD4⁺ T lymphocytes migrating in three-dimensional collagen lattices lack focal adhesions and utilize beta1 integrin-independent strategies for polarization, interaction with collagen fibers and locomotion. Eur J Immunol 28:2331–2343PubMedCrossRef

37.

Lammermann T, Bader BL, Monkley SJ et al (2008) Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453:51–55PubMedCrossRef

38.

Boissonnas A, Fetler L, Zeelenberg IS et al (2007) In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J Exp Med 204:345–356PubMedCrossRef

39.

Breart B, Lemaitre F, Celli S et al (2008) Two-photon imaging of intratumoral CD8⁺ T cell cytotoxic activity during adoptive T cell therapy in mice. J Clin Invest 118:1390–1397PubMedCrossRef

40.

Mrass P, Takano H, Ng LG et al (2006) Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med 203:2749–2761PubMedCrossRef

41.

Le Floc’h A, Jalil A, Vergnon I et al (2007) Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. J Exp Med 204:559–570PubMedCrossRef

42.

Thomsen AR, Nansen A, Madsen AN et al (2003) Regulation of T cell migration during viral infection: role of adhesion molecules and chemokines. Immunol Lett 85:119–127PubMedCrossRef

43.

Naito Y, Saito K, Shiiba K et al (1998) CD8⁺ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491–3494PubMed

44.

Wada Y, Nakashima O, Kutami R et al (1998) Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27:407–414PubMedCrossRef

45.

Budhu S, Loike JD, Pandolfi A et al (2010) CD8⁺ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues. J Exp Med 207:223–235PubMedCrossRef

46.

Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22:329–360PubMedCrossRef

47.

Johansson M, Denardo DG, Coussens LM (2008) Polarized immune responses differentially regulate cancer development. Immunol Rev 222:145–154PubMedCrossRef

48.

Kemp RA, Ronchese F (2001) Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. J Immunol 167:6497–6502PubMed

49.

Stockinger B, Veldhoen M, Martin B (2007) Th17 T cells: linking innate and adaptive immunity. Semin Immunol 19:353–361PubMedCrossRef

50.

Bettelli E, Carrier Y, Gao W et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238PubMedCrossRef

51.

Kimura A, Naka T, Nohara K et al (2008) Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci USA 105:9721–9726PubMedCrossRef

52.

Ouyang W, Kolls JK, Zheng Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28:454–467PubMedCrossRef

53.

Bettelli E, Korn T, Oukka M et al (2008) Induction and effector functions of T(H)17 cells. Nature 453:1051–1057PubMedCrossRef

54.

Miyahara Y, Odunsi K, Chen W et al (2008) Generation and regulation of human CD4⁺ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA 105:15505–15510PubMedCrossRef

55.

Kryczek I, Banerjee M, Cheng P et al (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114:1141–1149PubMedCrossRef

56.

Zhang JP, Yan J, Xu J et al (2009) Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 50:980–989PubMedCrossRef

57.

Wang L, Yi T, Kortylewski M et al (2009) IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 206:1457–1464PubMedCrossRef

58.

Kryczek I, Wei S, Szeliga W et al (2009) Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 114:357–359PubMedCrossRef

59.

Muranski P, Boni A, Antony PA et al (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112:362–373PubMedCrossRef

60.

Rudensky AY, Gavin M, Zheng Y (2006) FOXP3 and NFAT: partners in tolerance. Cell 126:253–256PubMedCrossRef

61.

Sakaguchi S (2004) Naturally arising CD4⁺ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531–562PubMedCrossRef

62.

Sakaguchi S, Miyara M, Costantino CM et al (2010) FOXP3⁺ regulatory T cells in the human immune system. Nat Rev Immunol 10:490–500PubMedCrossRef

63.

Tang Q, Bluestone JA (2008) The Foxp3⁺ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9:239–244PubMedCrossRef

64.

Hiraoka N, Onozato K, Kosuge T et al (2006) Prevalence of FOXP3⁺ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12:5423–5434PubMedCrossRef

65.

Kobayashi N, Hiraoka N, Yamagami W et al (2007) FOXP3⁺ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 13:902–911PubMedCrossRef

66.

Salama P, Phillips M, Grieu F et al (2009) Tumor-infiltrating FOXP3⁺ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186–192PubMedCrossRef

67.

Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917PubMedCrossRef

68.

Ueno Y, Moriyama M, Uchida T et al (2001) Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease. Hepatology 33:357–362PubMedCrossRef

69.

Sakamoto M, Hirohashi S, Shimosato Y (1991) Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22:172–178PubMedCrossRef

70.

(2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658–664

71.

Racanelli V, Rehermann B (2006) The liver as an immunological organ. Hepatology 43:S54–S62PubMedCrossRef

72.

Lee WY, Kubes P (2008) Leukocyte adhesion in the liver: distinct adhesion paradigm from other organs. J Hepatol 48:504–512PubMedCrossRef

73.

Shetty S, Lalor PF, Adams DH (2008) Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis. Toxicology 254:136–146PubMedCrossRef

74.

Braet F, Wisse E (2002) Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol 1:1PubMedCrossRef

75.

Wong J, Johnston B, Lee SS et al (1997) A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest 99:2782–2790PubMedCrossRef

76.

Fox-Robichaud A, Kubes P (2000) Molecular mechanisms of tumor necrosis factor alpha-stimulated leukocyte recruitment into the murine hepatic circulation. Hepatology 31:1123–1127PubMedCrossRef

77.

Bonder CS, Norman MU, Swain MG et al (2005) Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. Immunity 23:153–163PubMedCrossRef

78.

Lalor PF, Sun PJ, Weston CJ et al (2007) Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion. Hepatology 45:465–474PubMedCrossRef

79.

Oo YH, Shetty S, Adams DH (2010) The role of chemokines in the recruitment of lymphocytes to the liver. Dig Dis 28:31–44PubMedCrossRef

80.

Mantovani A, Savino B, Locati M et al (2010) The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev 21:27–39PubMedCrossRef

81.

Ishida T, Iida S, Akatsuka Y et al (2004) The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma. Clin Cancer Res 10:7529–7539PubMedCrossRef

82.

Ito A, Ishida T, Yano H et al (2009) Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model. Cancer Immunol Immunother 58:1195–1206PubMedCrossRef

83.

Yamamoto K, Utsunomiya A, Tobinai K et al (2010) Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia–lymphoma and peripheral T-cell lymphoma. J Clin Oncol 28:1591–1598PubMedCrossRef

84.

Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9:685–693PubMedCrossRef

85.

Morikawa S, Baluk P, Kaidoh T et al (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985–1000PubMed

86.

Dirkx AE, Oude Egbrink MG, Kuijpers MJ et al (2003) Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res 63:2322–2329PubMed

87.

Buckanovich RJ, Facciabene A, Kim S et al (2008) Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med 14:28–36PubMedCrossRef

88.

Hamzah J, Jugold M, Kiessling F et al (2008) Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 453:410–414PubMedCrossRef

89.

Shrimali RK, Yu Z, Theoret MR et al (2010) Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer. Cancer Res 70:6171–6180PubMedCrossRef

90.

Matsui O, Kadoya M, Kameyama T et al (1991) Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 178:493–497PubMed

91.

Hayashi M, Matsui O, Ueda K et al (2002) Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 225:143–149PubMedCrossRef

92.

Park YN, Yang CP, Fernandez GJ et al (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662PubMedCrossRef

93.

Ueda K, Terada T, Nakanuma Y et al (1992) Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. Hum Pathol 23:619–626PubMedCrossRef

Title: Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology
Author: Nobuyoshi Hiraoka
Publication date: 01-12-2010
Publisher: Springer Japan
Published in: International Journal of Clinical Oncology / Issue 6/2010
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-010-0130-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2010

Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management

List of reviewers 2009–2010

Improvement of long-term survival of colorectal cancer in Japanese-Americans of Hawaii from 1990 to 2001

A large cystic gastrointestinal stromal tumor of the rectum in the retrorectal space

Review of primary unknown cancer: cases referred to the National Cancer Center Hospital East

Cranial nerve deficit caused by skull metastasis of prostate cancer: three Japanese castration-resistant prostate cancer cases

Keynote webinar | Spotlight on antibody–drug conjugates in cancer